Supplemental Grant Application Instructions II-2 . Scenario C. Exempt Human Subjects Research If all of the proposed human subjects research meets the criteria for one or more of the exemptions from the requirements in the HHS regulations (46.101(b)) (see Part III Section 3 under Human Subjects Research
Adults with one of the above listed conditions who have not received any pneumococcal vaccine should get a dose of PCV13 first and should also continue to receive the recommended doses of PPSV23. Ask your health care provider for details.
Fluoroquinolones are featured prominently in The American Thoracic Society guidelines for the treatment of hospital-acquired pneumonia. The Society recommends fluoroquinolones not be used as a first-line agent for community-acquired pneumonia, instead recommending macrolide or doxycycline as first-line agents.